Volume 30, Issue 6, June 2024

Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study

• Abstract
• View article
• Supplementary data

An Atlas Characterizing the Shared Genetic Architecture of Inflammatory Bowel Disease with Clinical and Behavioral Traits

• Abstract
• Lay summary
• View article
• Supplementary data

Niclosamide Enema for Active Distal Ulcerative Colitis: A Phase 1, Open-Label Study

• Abstract
• View article

A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis

• Abstracts
• View article
• Supplementary data

Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress

• Abstract
• View article

HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients

• Abstract
• Lay summary
• View article

Mucosal α4β7+ Lymphocytes and MAdCAM+ Venules Predict Response to Vedolizumab in Ulcerative Colitis

• Abstract
• View article

The Communicating Needs and Features of IBD Experiences (CONFIDE) Study: US and European Patient and Health Care Professional Perceptions of the Experience and Impact of Symptoms of Moderate-to-Severe Ulcerative Colitis

• Abstract
• View article
• Supplementary data

Defining the Roles of Inflammatory Bowel Disease Clinical Pharmacists in the United States: A Systematic Review and National RAND/UCLA Consensus

• Abstract
• View article
• Supplementary data

Outcomes of a Comprehensive Specialist Inflammatory Bowel Disease Nursing Service

• Abstracts
• View article

Single Nucleotide Polymorphisms of the MEFV Gene E148Q Are Highly Associated With Disease Phenotype in Crohn’s Disease

• Abstract
• Lay summary
• View article
• Supplementary data

Differential Impact of Smoking on Methylome and Transcriptome in Crohn’s Disease and Ulcerative Colitis

• Abstract
• Lay summary
• View article
• Supplementary data

2ʹ-Hydroxycinnamaldehyde Alleviates Intestinal Inflammation by Attenuating Intestinal Mucosal Barrier Damage Via Directly Inhibiting STAT3

• Abstracts
• Lay summary
• View article
• Supplementary data

Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus

• Abstract
• View article
• Supplementary data

Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach

• Abstracts
• Lay summary
• View article

Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study

• Extract
• Lay summary
• View article

Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression

• Extract
• Lay summary
• View article

Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiation for Acute Severe Ulcerative Colitis: A Case Series in the United States

• Extract
• Lay summary
• View article

Correction to: Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study

• Extract
• View article

Freeing Time and Reducing Costs: The Value of a Specialized Nursing Service in IBD

• Extract
• Lay summary
• View article

Reply: “Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-Modulating Therapy for Inflammatory Bowel Disease”

• Extract
• View article

Is Ulcerative Colitis Really Ever “Cleared?”

• Extract
• View article

Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease

• Extract
• View article

Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease

• Extract
• View article

The Association of Extra-oral Halitosis With Small Intestinal Bacterial Overgrowth in Inflammatory Bowel Disease

• Extract
• View article